European Case Law Identifier: | ECLI:EP:BA:2006:T056204.20060214 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 14 February 2006 | ||||||||
Case number: | T 0562/04 | ||||||||
Application number: | 93902233.1 | ||||||||
IPC class: | C07K 1/18 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Process for recovering a high-purity virus-inactivated factor VIII/von Willebrand factor complex by anion exchanger chromatography | ||||||||
Applicant name: | Octapharma AG | ||||||||
Opponent name: | Baxter Healthcare S.A. | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Admissibility of late-filed documents - (yes) Remittal - (no) Main request - novelty (no) Auxiliary request - added subject-matter, extension of scope of protection (no), clarity, novelty, sufficiency of disclosure, inventive step (yes) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t040562eu1.html
Date retrieved: 17 May 2021
6 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.Case Law Book: II Conditions to be met by an Application
XCLR II E 2.6.2 From product or product-by-process claim to a claim directed to a process for manufacturing/preparing the product, and vice versa